Company intelligence / Profile preview

HealthLytix

San Diego, California, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

HealthLytix developed FDA-cleared software (CT CoPilot, RSI-MRI+ for prostate) that improved workflow, accuracy, and clinical outcomes for radiologists. Peer-reviewed and clinical site use demonstrated improved productivity and diagnostic confidence. RSI-MRI+ for Prostate was specifically highlighted as a breakthrough for early cancer detection; CT CoPilot was shown to significantly improve reader certainty and efficiency in head CT exam interpretation.

Therapeutic areas: NeurologyOncology
Modalities: Device (FDA-cleared imaging software)Non-pharmacological therapy (diagnostic/imaging software)
Industry: Medical Imaging

Partnerships

Nuance (AI Marketplace, integration into PowerScribe radiology software)Dash Genomics (genetic risk analysis collaboration for Alzheimer’s)

Beyond the preview

Go deeper on HealthLytix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HealthLytix.

Explore the full profile